Moderna | MRNA - Current Assets



Moderna reported $6.17B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Acadia Pharmaceuticals USD 960.55M 89.61M Jun/2025
Adcock Ingram Holdings ZAR 5.12B 234.71M Dec/2024
Agios Pharmaceuticals USD 1.02B 50.85M Jun/2025
Alnylam Pharmaceuticals USD 3.64B 375.44M Jun/2025
Amgen USD 26.73B 195M Jun/2025
Arrowhead Research USD 946.92M 188.3M Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
BioMarin Pharmaceutical USD 3.81B 337.43M Jun/2025
Celltrion KRW 5.46T 122.95B Mar/2025
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Incyte USD 3.64B 411.91M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 516.3M 26.69M Jun/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Moderna USD 6.17B 595M Jun/2025
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Pharma Mar EUR 249.4M 13.39M Jun/2025
Qiagen NV USD 1.82B 76.12M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Sarepta Therapeutics USD 2.66B 224.45M Jun/2025
Sartorius EUR 2.17B 7.5M Jun/2025
Sino Biopharmaceutical CNY 24.69B 536.66M Dec/2024
Tilray USD 707.34M 18.54M Nov/2024
Ultragenyx Pharmaceutical USD 719.79M 20.63M Jun/2025
United Therapeutics USD 3.83B 112.9M Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025